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Abstract: Antirheumatic and analgesics drugs are the most commonly prescribed medications for treatment of acute and chronic 
pain. Frequent application of these agents often causes adverse effects. So, in order to avoid the incidence of side effects, topical 
analgesics are treatment of choice for localized muscle pain. Topical analgesics offer the potential to provide the same analgesic 
relief provided by oral analgesics but with minimal adverse systemic effects. The aim of this study is to present the preparation and 
characterization of topical analgesic gel named “Russian water”. Gel is composed of Menthol, Benzocaine, Procaine HCl as topical 
analgesic agents indicated for temporary relief of pain. Obtained results showed prolonged analgesic effect compared with liquid 
ethanol solution composed of the same components.  
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1. Introduction 
Antirheumatic and analgesics drugs are the most 
commonly used agents to treat diseases of the 
musculoskeletal system and to alleviate all sorts of 
pain caused from different origins [1, 2]. However, 
oral application of these agents often causes side 
effects [3, 4]. So combined therapy with systemic and 
local effect agents intended for topical use wherever 
possible, especially in physical therapy, would be 
treatment of choice [2, 5, 6, 7, 8]. 
Various formulations of dosage frms, by 
composition and consistency, allow different 
therapeutic approach, which is suitable for achieving 
the desired therapeutic effect and for being capable to 
adapt to the physiotherapist treatment [9, 10].  
According to the regulations of the pharmacopoeia 
or to other regulations, galenic drugs are made in 
small batches in a galenic laboratory intended for 
direct administration.  
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According to the health requirements, the 
preparation of pharmaceutical dosage formed in a 
galenic laboratory, mainly aims to provide a dosage 
form, which is designed as an opportunity for changes 
in the composition and consistency of the product.     
The usage of this drug, immediately after the 
preparation, reduces the need for adding more funds to 
stabilize and to ensure longer shelf life.  
Obtaining the quality of this drug product satisfies 
the standards, maintains or enhances the therapeutic 
properties, requires appropriate conditions for a 
preparation and knowledge of all the components 
properties, technological process and requirements for 
the finished product as well.  
The usage of the traditional liquid, a pharmaceutical 
product known as “Russian water”, which contains: 
alcohol, menthol, procaine hydrochloride and 
benzocaine, is well received and accepted by the 
patients and the physiotherapists, but it also has some 
negative sides, such as short effect, it is easily volatile, 
it acts on the surface and cannot be recommended as a 
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massage supplement. On the other hand, gels are a 
dosage forms for external use that can be applied 
easily to tie up to the skin and to enable the drug to 
heal the affected area, and it can realize deep action, 
such as the ability to quickly penetrate multi-layers on 
the skin, to be easily rinsed from the site of 
application and generally does not irritate the skin, 
which is largely satisfying for our requirements.  
The aim of this study is to present the production of 
a gel named “Russian water”, composed of Menthol, 
Benzocaine, Procaine HCl, in the form of a gel. Gel 
was prepared for Specialists Services of 
Physiotherapy Department, in General Hospital in 
Ohrid.  
2. Materials and Methods 
For the formulation and preparation the following 
active substances were used: Menthol (Alkaloid), 
Benzocaine (Sigma Aldrich), Procaine HCl (Sigma 
Aldrich) at the recommended doses and ingredients: 
Carbopol 940 (Sigma Aldrich) Glycerol, (Alkaloid) 
Triethylenetetramine (Sigma Aldrich) and Aqua 
distillate. Gel with menthol, benzocaine and procaine 
HCl was prepared in the galenic laboratory in Ohrid 
-General Hospital. Used ingredients and a 
compounding procedure are presented in Table 1. 
Production of the base gel I was represented on Fig. 1.  
In the step 1, preparation of base gel, Carbopol 940 
and aqua distillate 50 mL, were left to bulge. Then 
glycerolum was gradually added and mixed to achieve 
good homogenization. After that, triethylenetetraamin 
was added and mixed again until thick gel was 
obtained. 
In the step 2, preparation of healing gel, the 
menthol was grinded through a sieve, and it was 
measured in the prescribed amount.  
3. Results and Discussion 
The obtained gel is a homogeneous product with 
milk appearance. The high degree of pulverization of 
the components should improve solubility and ensure 
uniform distribution of insoluble components in the 
mixture. The process of mixing equal amounts of the 
basic mixture and pulverized substance also provides 
uniform distribution of the components, and the   
high density  of the base  gel reduces  the possibility of 
 
Table 1  Analgesic components of “Russian water”.  
Agent Dose  
Menthol 4 g 
Benzocaine 2 g 
Procaine HCl 2 g 
Base gel 192 g 
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sedimentation [1, 9, 11, 12, 13]. Menthol is practically 
insoluble in water and because of its sole distribution 
in the preparation is pulverized for its incorporation 
into the system. Benzocaine is poorly soluble in water 
with an appropriate pulverization, mixing improved 
solubility and its uniform distribution in the product. 
The procedure of mixing and gradual addition of a 
small amount concentrated procaine hydrochloride 
solution reduces the possibility of decomposition of 
the gel structure under the influence of the potential 
ionic solution [8, 14].  
The obtained gel is packaged in plastic recipients of 
200 mL, closed with a suitable stopper and signed 
with red signature marked “For external use” [15]. It 
is used topically by applying to the affected area 
and/or with good rubbing in physical therapy. The 
product has a short shelf life and is prepared 
immediately before use, and to ensure the quality of 
the product it is recommended to be kept at a room 
temperature in well-closed recipients. During 
application it gives pleasant cooling sensation and 
pain relief, and easily rinse out with water. It is not 
toxic and does not cause skin irritation.  
The product can be prepared in galenic laboratory. 
The easy application and efficiency makes it 
acceptable to patients [16]. This agent forms film on 
the place of application and compared with alcohol 
solution represents prolonged analgesic activity     
[1, 17]. 
4. Conclusions 
Topical analgesics are a promising class of agents 
for treatment of chronic pain. They can be used to 
supplement or replace systemic analgesics, and 
improve clinical outcome while reducing the side 
effects and morbidity associated with systemic agents. 
The obtained results of the treatment of patients 
according to the investigation of the staff that operated 
and the practical patients show that this gel is with a 
prolonged analgesic activity compared with the liquid 
preparation, with an easy and safe application, a 
pleasant cooling sensation and a pain relief, also an 
easy flushing and an increased satisfaction of 
therapists and patients. 
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